尼日利亚即时病毒载量检测结果及时性改善人类免疫缺陷病毒监测
在尼日利亚两家中心开展开放标签随机对照试验,评估即时病毒载量(POC VL)与标准检测(SOC)对新启动抗逆转录病毒治疗(ART)患者的监测时效。POC组获得结果中位0.1天,SOC组143.1天,P<.0001;确认病毒学失败者POC组换二线方案中位0天,SOC组66天,P=.03。
要点
- POC组获得病毒载量结果中位0.1天,SOC组143.1天,P<.0001。
- 确认病毒学失败者POC组换二线方案中位0天,SOC组66天,P=.03。
- POC病毒载量检测改善结果及时性与临床管理时效。
核心结论
- 即时病毒载量检测显著改善患者获得病毒载量结果的及时性并用于有效的HIV临床管理。
- 在病毒载量失败的患者中,即时监测使患者能迅速换用二线抗逆转录病毒治疗方案。
研究设计与样本
- 开放标签、随机对照试验,纳入新启动抗逆转录病毒治疗的初治患者。
- 在尼日利亚乔斯大学教学医院和Zamko综合健康中心评估使用Cepheid Xpert的即时病毒载量监测与标准病毒载量检测的临床结局。
- 2018年4月至2019年10月筛查696名未接受过抗逆转录病毒治疗者,273例随机至即时检测组,268例随机至标准检测组。
主要发现
- 即时检测组获得病毒载量结果中位0.1天(四分位距0.1-0.2),标准检测组中位143.1天(四分位距56.0-177.1),P<.0001。
- 确认病毒学失败的即时检测组换二线方案中位0天(四分位距0-28),标准检测组中位66天(四分位距63-123),P=.03。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Human immunodeficiency virus (HIV) viral load (VL) monitoring is critical for antiretroviral therapy (ART) management. Point-of-care (POC) VL testing has been reported to be feasible and preferred over standard-of-care (SOC) testing in many low- and middle-income country settings where rapid results could improve patient outcomes. METHODS: The timeliness of receipt of VL results was evaluated in an open-label, randomized, controlled trial among patients newly initiating ART. Clinical outcomes with POC VL monitoring using Cepheid Xpert vs SOC VL at Jos University Teaching Hospital and Comprehensive Health Centre Zamko in Nigeria were assessed. We determined time between specimen collection and recording of VL in patient charts, receipt of results, and ART switch for those who met virologic failure criteria. RESULTS: Between April 2018 and October 2019, we screened 696 ART-naive individuals; 273 were randomized to POC and 268 to SOC HIV-1 VL testing. Participants in the POC arm received VL results significantly faster than those in the SOC arm (0.1 median days, interquartile range [IQR], 0.1-0.2 vs 143.1 days, IQR, 56.0-177.1, respectively; P < .0001). Participants in the POC arm with confirmed virologic failure vs those in the SOC arm were switched more rapidly to a second-line regimen (0 median days, IQR, 0-28 vs 66 days, IQR, 63-123, respectively; P = .03). CONCLUSIONS: POC VL testing resulted in significant improvement in the timeliness of VL result receipt by patients and use for effective HIV clinical management. In patients experiencing VL failure, POC monitoring enabled prompt switching to second-line ART regimens. CLINICAL TRIALS REGISTRATION: NCT03533868.
引用
- Chaplin B, Agbaji O, Reyes Nieva H, et al. Timeliness of Point-of-Care Viral Load Results Improves Human Immunodeficiency Virus Monitoring in Nigeria. Clin Infect Dis. 2023. PMID: 35872644. doi:10.1093/cid/ciac609
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。